{"id":"https://openalex.org/W2113100908","doi":"https://doi.org/10.1517/13543784.9.10.2331","title":"Neuroimmunophilin ligands: evaluation of their therapeutic potential for the treatment of neurological disorders","display_name":"Neuroimmunophilin ligands: evaluation of their therapeutic potential for the treatment of neurological disorders","alternate_titles":[],"publication_year":2000,"publication_date":"2000-10-01","ids":{"openalex":"https://openalex.org/W2113100908","doi":"https://doi.org/10.1517/13543784.9.10.2331","mag":"2113100908","pmid":"https://pubmed.ncbi.nlm.nih.gov/11060810"},"language":"en","primary_location":{"id":"doi:10.1517/13543784.9.10.2331","doi":"https://doi.org/10.1517/13543784.9.10.2331","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543784.9.10.2331","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2113100908"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111749188","display_name":"Bruce G. Gold","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Bruce G Gold","raw_affiliation_strings":["Center for Research on Occupational and Environmental Toxicology (CROET) and the Department of Cell and Developmental Biology, Oregon Health Sciences University, Portland, Oregon, 97201-3098, USA. gold@ohsu.edu","Center for Research on Occupational and Environmental Toxicology (CROET)/L606, Oregon Health Sciences University, 3181 S.W. Sam Jackson Park Road, Portland, Oregon 97201-3098, USA. gold@ohsu.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Research on Occupational and Environmental Toxicology (CROET) and the Department of Cell and Developmental Biology, Oregon Health Sciences University, Portland, Oregon, 97201-3098, USA. gold@ohsu.edu","institution_ids":["https://openalex.org/I165690674"]},{"raw_affiliation_string":"Center for Research on Occupational and Environmental Toxicology (CROET)/L606, Oregon Health Sciences University, 3181 S.W. Sam Jackson Park Road, Portland, Oregon 97201-3098, USA. gold@ohsu.edu","institution_ids":["https://openalex.org/I165690674"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5111749188"],"corresponding_institution_ids":["https://openalex.org/I165690674"],"apc_list":null,"apc_paid":null,"fwci":1.2771,"has_fulltext":false,"cited_by_count":145,"citation_normalized_percentile":{"value":0.77101449,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"9","issue":"10","first_page":"2331","last_page":"2342"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10483","display_name":"Nerve injury and regeneration","score":0.426800012588501,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10483","display_name":"Nerve injury and regeneration","score":0.426800012588501,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12620","display_name":"Signaling Pathways in Disease","score":0.2434999942779541,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.13529999554157257,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fk506","display_name":"FK506","score":0.8980000019073486},{"id":"https://openalex.org/keywords/cyclosporine","display_name":"cyclosporine","score":0.9959999918937683},{"id":"https://openalex.org/keywords/fkbp12","display_name":"FKBP12","score":0.7630000114440918},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9010000228881836},{"id":"https://openalex.org/keywords/nerve-regeneration","display_name":"nerve regeneration","score":0.906000018119812},{"id":"https://openalex.org/keywords/calcineurin-inhibition","display_name":"calcineurin inhibition","score":0.7580000162124634},{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.5910000205039978},{"id":"https://openalex.org/keywords/traumatic-nerve-injury","display_name":"traumatic nerve injury","score":0.7160000205039978},{"id":"https://openalex.org/keywords/spinal-cord-injury","display_name":"spinal cord injury","score":0.7910000085830688},{"id":"https://openalex.org/keywords/neurodegenerative-diseases","display_name":"neurodegenerative diseases","score":0.7929999828338623},{"id":"https://openalex.org/keywords/diabetic-neuropathy","display_name":"diabetic neuropathy","score":0.8669999837875366},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9909999966621399},{"id":"https://openalex.org/keywords/vinca-alkaloids","display_name":"vinca alkaloids","score":0.906000018119812},{"id":"https://openalex.org/keywords/peripheral-nerve-regeneration","display_name":"peripheral nerve regeneration","score":0.5529999732971191}],"concepts":[{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.8286174535751343},{"id":"https://openalex.org/C128057223","wikidata":"https://www.wikidata.org/wiki/Q420566","display_name":"Calcineurin","level":3,"score":0.631405234336853},{"id":"https://openalex.org/C92020748","wikidata":"https://www.wikidata.org/wiki/Q420457","display_name":"Neurotrophin","level":3,"score":0.6200771331787109},{"id":"https://openalex.org/C2780252810","wikidata":"https://www.wikidata.org/wiki/Q1455316","display_name":"Immunosuppression","level":2,"score":0.6018646359443665},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.5264424085617065},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5204218029975891},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.482397198677063},{"id":"https://openalex.org/C134139212","wikidata":"https://www.wikidata.org/wiki/Q24719927","display_name":"Trk receptor","level":4,"score":0.4452016353607178},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.44212576746940613},{"id":"https://openalex.org/C160539049","wikidata":"https://www.wikidata.org/wiki/Q3064187","display_name":"Neurotrophic factors","level":3,"score":0.4406232237815857},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2847575545310974},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.22113347053527832},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.21931791305541992},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.14912879467010498}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001930","descriptor_name":"Brain Injuries","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002349","descriptor_name":"Carpal Tunnel Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009416","descriptor_name":"Nerve Regeneration","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009416","descriptor_name":"Nerve Regeneration","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D009422","descriptor_name":"Nervous System Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013119","descriptor_name":"Spinal Cord Injuries","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D016572","descriptor_name":"Cyclosporine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016572","descriptor_name":"Cyclosporine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020104","descriptor_name":"Immunophilins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020104","descriptor_name":"Immunophilins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D022061","descriptor_name":"Tacrolimus Binding Protein 1A","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D022061","descriptor_name":"Tacrolimus Binding Protein 1A","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1517/13543784.9.10.2331","doi":"https://doi.org/10.1517/13543784.9.10.2331","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543784.9.10.2331","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},{"id":"pmid:11060810","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11060810","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on investigational drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":92,"referenced_works":["https://openalex.org/W80326990","https://openalex.org/W151414047","https://openalex.org/W175344519","https://openalex.org/W1511792975","https://openalex.org/W1522775437","https://openalex.org/W1528505919","https://openalex.org/W1554773849","https://openalex.org/W1591881385","https://openalex.org/W1657897383","https://openalex.org/W1834422411","https://openalex.org/W1923097818","https://openalex.org/W1965388311","https://openalex.org/W1968671288","https://openalex.org/W1969612832","https://openalex.org/W1974892577","https://openalex.org/W1976441097","https://openalex.org/W1978197119","https://openalex.org/W1978559408","https://openalex.org/W1985971810","https://openalex.org/W1986094270","https://openalex.org/W1990918954","https://openalex.org/W1991893050","https://openalex.org/W1999694263","https://openalex.org/W2003031313","https://openalex.org/W2003034546","https://openalex.org/W2004391423","https://openalex.org/W2004625482","https://openalex.org/W2007749506","https://openalex.org/W2009032298","https://openalex.org/W2009058877","https://openalex.org/W2009065142","https://openalex.org/W2016854943","https://openalex.org/W2019132217","https://openalex.org/W2020597127","https://openalex.org/W2023131407","https://openalex.org/W2028547922","https://openalex.org/W2031705137","https://openalex.org/W2036539375","https://openalex.org/W2039721791","https://openalex.org/W2041561339","https://openalex.org/W2042740099","https://openalex.org/W2043897928","https://openalex.org/W2049481822","https://openalex.org/W2055183364","https://openalex.org/W2057476516","https://openalex.org/W2057767803","https://openalex.org/W2060079535","https://openalex.org/W2060090607","https://openalex.org/W2060733653","https://openalex.org/W2061931493","https://openalex.org/W2062007753","https://openalex.org/W2062805042","https://openalex.org/W2064762827","https://openalex.org/W2067957091","https://openalex.org/W2070564946","https://openalex.org/W2072448872","https://openalex.org/W2074243828","https://openalex.org/W2075702813","https://openalex.org/W2076384379","https://openalex.org/W2076811542","https://openalex.org/W2077769042","https://openalex.org/W2078034391","https://openalex.org/W2079497446","https://openalex.org/W2082215172","https://openalex.org/W2084402494","https://openalex.org/W2094893926","https://openalex.org/W2095035055","https://openalex.org/W2098257766","https://openalex.org/W2100789276","https://openalex.org/W2101408825","https://openalex.org/W2101508627","https://openalex.org/W2101996466","https://openalex.org/W2110715762","https://openalex.org/W2121108041","https://openalex.org/W2126706634","https://openalex.org/W2135128039","https://openalex.org/W2137341857","https://openalex.org/W2137653016","https://openalex.org/W2140313980","https://openalex.org/W2143302994","https://openalex.org/W2151601807","https://openalex.org/W2153842250","https://openalex.org/W2159119513","https://openalex.org/W2162812410","https://openalex.org/W2167839140","https://openalex.org/W2168435609","https://openalex.org/W2202099835","https://openalex.org/W2329573625","https://openalex.org/W2334260351","https://openalex.org/W2419411847","https://openalex.org/W2782175582","https://openalex.org/W3209643541"],"related_works":["https://openalex.org/W145226892","https://openalex.org/W1999167110","https://openalex.org/W2416028138","https://openalex.org/W2067957091","https://openalex.org/W1967050691","https://openalex.org/W2162812410","https://openalex.org/W2384811957","https://openalex.org/W7039812697","https://openalex.org/W1996216705","https://openalex.org/W2091984682"],"abstract_inverted_index":{"Neuroimmunophilin":[0],"ligands":[1,59,95],"are":[2,65],"a":[3,39,237,264],"class":[4,182],"of":[5,14,41,44,161,180,183,188,200,209,239,255,258,263,266],"compounds":[6,29,184,259],"that":[7,57,64,77,92,217],"hold":[8],"great":[9],"promise":[10],"for":[11,154,177,185,251,260],"the":[12,32,68,82,87,133,145,162,178,186,193,197,207,234,261],"treatment":[13,187,262],"nerve":[15,25,47,228,275],"injuries":[16],"and":[17,49,98,113,120,135,227,231,276,285,292],"neurological":[18,190,268],"disease.":[19],"In":[20],"contrast":[21],"to":[22,67,127,139,195],"neurotrophins":[23],"(e.g.,":[24,72,273,281],"growth":[26],"factor),":[27],"these":[28,168],"readily":[30],"cross":[31],"blood-brain":[33],"barrier,":[34],"being":[35,236],"orally":[36],"effective":[37],"in":[38,104],"variety":[40,265],"animal":[42],"models":[43],"ischaemia,":[45],"traumatic":[46,271],"injury":[48,272],"human":[50,189,267],"neurodegenerative":[51,286],"disorders.":[52],"A":[53,97,112,174],"further":[54],"distinction":[55],"is":[56,91,157],"neuroimmunophilin":[58,94],"act":[60],"via":[61,141,171,206],"unique":[62],"receptors":[63,71],"unrelated":[66],"classical":[69],"neurotrophic":[70],"trk),":[73],"making":[74],"it":[75],"unlikely":[76],"clinical":[78],"trials":[79],"will":[80],"encounter":[81],"same":[83],"difficulties":[84],"found":[85],"with":[86],"neurotrophins.":[88],"Another":[89],"advantage":[90],"two":[93],"(cyclosporin":[96],"FK-506)":[99],"have":[100,123],"already":[101],"been":[102,124],"used":[103],"humans":[105],"(as":[106],"immunosuppressant":[107,204],"drugs).":[108],"Whereas":[109],"both":[110],"cyclosporin":[111],"FK-506":[114,119,201],"demonstrate":[115],"neuroprotective":[116,134],"actions,":[117],"only":[118],"its":[121,203],"derivatives":[122],"clearly":[125],"shown":[126],"exhibit":[128],"significant":[129],"neuroregenerative":[130,136,146,198],"activity.":[131],"Accordingly,":[132],"properties":[137],"seem":[138],"arise":[140,170],"different":[142,218],"mechanisms.":[143],"Furthermore,":[144],"property":[147,199],"does":[148],"not":[149],"involve":[150],"calcineurin":[151,172],"inhibition":[152],"(essential":[153],"immunosuppression).":[155],"This":[156],"important":[158],"since":[159],"most":[160],"limiting":[163],"side":[164],"effects":[165],"produced":[166],"by":[167],"drugs":[169],"inhibition.":[173],"major":[175],"breakthrough":[176],"development":[179,208,254],"this":[181],"disorders":[191],"was":[192],"ability":[194],"separate":[196],"from":[202],"action":[205],"non-immunosuppressant":[210],"(non-calcineurin":[211],"inhibiting)":[212],"derivatives.":[213],"Further":[214],"studies":[215],"revealed":[216],"receptor":[219,241,245],"subtypes,":[220],"or":[221],"FK-506-binding":[222],"proteins":[223,247],"(FKBPs),":[224],"mediate":[225],"immunosuppression":[226],"regeneration":[229],"(FKBP-12":[230],"FKBP-52,":[232],"respectively,":[233],"latter":[235],"component":[238],"steroid":[240,244],"complexes).":[242],"Thus,":[243],"chaperone":[246],"represent":[248],"novel":[249,256],"targets":[250],"future":[252],"drug":[253],"classes":[257],"disorders,":[269],"including":[270],"peripheral":[274],"spinal":[277],"cord),":[278],"chemical":[279],"exposure":[280],"vinca":[282],"alkaloids,":[283],"Taxol)":[284],"disease":[287],"(e.g.":[288],",":[289],"diabetic":[290],"neuropathy":[291],"Parkinson's":[293],"disease).":[294]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2113100908","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
